LOS GATOS, CA / ACCESSWIRE / May 31, 2022 / Tenon Medical, Inc. ("Tenon" or the "Company"), a medical device company that has developed a proprietary, U.S. Food and Drug Administration ("FDA") cleared surgical implant system for sacroiliac joint ("SI Joint") fixation/fusion surgery, today announced the Company has posted its new corporate presentation accessible via the Company's Investor Relations website at http://ir.tenonmed.com/.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed a proprietary, FDA cleared surgical implant system, which is designed to optimize SI-Joint fixation / fusion surgery and corresponding outcomes. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space. For more information, please visit https://www.tenonmed.com/.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View source version on accesswire.com:
https://www.accesswire.com/703312/Tenon-Medical-Inc-Announces-the-Posting-of-New-Corporate-Presentation-via-the-Investor-Relations-Website
